📰 Patient Support Program News

Page 3 - Patient Support Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patient Support Program. Real-time updates on events, politics, business and more.

Celltrion USA Launches Yuflyma® (adalimumab-aaty), a Humira® (adalimumab) biosimilar, in the United States

July 3, 2023

JERSEY CITY, N.J.--(BUSINESS WIRE)--Jul 2, 2023--

New Jersey United States Informationfor Yuflyma Hidradenitis Suppurativa Lindsey Lucenta Tom Nusbickel

Source: valdostadailytimes.com

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 1, 2023

Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system

New Jersey United States Jersey City Christopher Hansung Ko Samsung Bioepis Kevin Ali

Source: marketscreener.com

Patient Support Program (PSP) Optimization: A Customer Story

May 15, 2023

- PMLiVE

Patient Support Program Impetus Digital

Source: pmlive.com

FDA Approves Merck's KEYTRUDA® (pembrolizumab) in Combination With Padcev® (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer

April 3, 2023

First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients ... | April 3, 2023

United States Seagen Padcev Eliav Barr Approval Program Drug Administration Patient Support Program

Source: marketscreener.com

FDA Converts to Full Approval Indication for KEYTRUDA® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors

March 29, 2023

KEYTRUDA is approved for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors, as determined by an FDA-approved test, that have progressed... | March 29, 2023

United States Luisa Diaz Jr Scot Ebbinghaus Merck Co Inc Merck Patient Support Program Memorial Sloan Kettering Cancer Center

Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Report Demonstrates that Pharmacist-Administered Vaccinations Have Increased Since the Onset of the Covid-19 Pandemic

January 18, 2023

Global Healthy Living Foundation and IQVIA Analysis Highlights the Critical Function Pharmacies Play in Expanding Vaccination Services to Decrease Healthcare

United States Creakyjoints Espa Seth Ginsberg Robert Popovian Us Congress Institute For Human Data Science

Source: einnews.com

Fresenius Kabi Introduces KabiCare Nutrition Resources for U.S. Parenteral Nutrition Products

December 5, 2022

Fresenius Kabi announced today it has introduced KabiCare Nutrition Resources in the United States as part of its KabiCare patient support program. The KabiCare Nutrition Resources program provides support

United States Bad Homburg Lake Zurich Tom Tsilipetros Matt Kuhn Fresenius Kabi

Source: finanznachrichten.de

NewCa.com: (Pr)VYEPTI® (Eptinezumab For Injection) Is Now

November 5, 2022

Lundbeck Canada Inc. is pleased to announce that VYEPTI® (eptinezumab for injection) is now available for physicians in Canada to prescribe to their patients.

Wendy Gerhart Michal Juul Elizabeth Leroux Lundbeck Canada Inc Patient Support Program Lundbeck Canada

Source: newca.com

Alvotech (ALVO) Q2 2022 Earnings Call Transcript

September 1, 2022

Alvotech (NASDAQ:NASDAQ:ALVO) Q2 2022 Earnings Conference Call September 1, 2022 08:00 ET Company Participants Benedict Stephan - Investor Relations Robert Wessman - Executive Chairman...

New York United States Joel Morales Karen Marchetti Mark Leonard Ming Li

Source: seekingalpha.com